ArticleCancer research and treatment2023

Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant Chemotherapy.

Eun-Gyeong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.